New York University Skip to Content Skip to Search Skip to Navigation Skip to Sub Navigation

Protein Molecule May Offer Method for Treating Untreatable Cancers

January 21, 2014

The effective treatment of cancer requires the ability to destroy cancerous cells. Nearly one-third of all cancers today involve mutations of the Kras gene, which has proven resistant to existing cancer treatments. The current prognosis for patients with mutant Kras cancers is poor because there is no effective treatment. However, recent analysis by Valerie Wells of NYU London and Livio Mallucci of King’s College London may present a new method to combat these untreatable cancers.


In a feature article in Drug Discovery Today, Wells and Mallucci discuss the current therapeutic strategies and their limitations, highlighting a new way forward using the recombinant form of a physiological protein molecule, beta-GBP, which has proven to be effective against human Kras-driven tumors in animal models.


There are several significant aspects to their discovery. First, the beta-GBP molecule they have identified kills mutant Kras and other cancer cells by activating alternative routes to destroy cancer while leaving normal cells unharmed. Second, the beta-GBP molecule is naturally occurring in the body and therefore would avoid the complexity of current combinatorial therapies and the issues of drug resistance, toxicity and all side effects experienced with chemotherapy. Finally, translation of beta-GBP to the clinic, facilitated by its physiological nature, could open a new therapeutic opportunity representing a significant step forward in the treatment of cancers resistant to all current methods.

Read the article in ScieneDirect.

This Article is in the following Topics:
Research

Type: Article

Protein Molecule May Offer Method for Treating Untreatable Cancers

Search News



NYU In the News

CUSP Unveils its “Urban Observatory”

Crain’s New York Business profiled CUSP’s “Urban Observatory” that is continuously photographing lower Manhattan to gather scientific data.

Post-Sandy Upgrades at the Langone Medical Center

NY1 reported on the major post-Sandy upgrades and renovations made at the Medical Center to protect the hospital from future catastrophic storms.

Steinhardt Research Helps Solve Tough Speech Problems.

The Wall Street Journal reported on research at Steinhardt’s Department of Communicative Sciences and Disorders, including an interview with Assistant Professor Tara McAllister Byun, that uses ultrasound to help solve tough speech problems.

Times Column Lauds Professor Stevenson’s New Memoir

New York Times columnist Nicholas Kristof wrote a column about “Just Mercy,” a new memoir by Law Professor Bryan Stevenson, the founder of the Equal Justice Initiative, whom he noted has been called America’s Nelson Mandela.

Entrepreneurship Lab Opens at NYU

Crain’s New York Business covered the opening of the Mark and Debra Leslie Entrepreneurial eLab, which will be the headquarters for NYU’s Entrepreneurial Institute and all of the University’s programs aimed at promoting innovation and startups.

NYU Footer